Generics 30

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Bromazepam manufacturers

30 products found

Filters

30 products found

bromazepam

Capsules 1.5 mg, 3 mg, 6 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

bromazepam

Oral drops 2.5 mg/ml - 20 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16171
Since the 1900s, a European pharmaceutical firm has been there for health professionals and health organizations, sharing healthcare and patient quality of life via a culture built on passion, integrity, and transparency. The Company's most noticeable values are its people-oriented policy, which applies to all customers and collaborators, as well as its constant and attentive attention to national and worldwide markets.

Manufacturer usually replies in 5 days

bromazepam

Capsules 1.5 mg, 3 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16171
Since the 1900s, a European pharmaceutical firm has been there for health professionals and health organizations, sharing healthcare and patient quality of life via a culture built on passion, integrity, and transparency. The Company's most noticeable values are its people-oriented policy, which applies to all customers and collaborators, as well as its constant and attentive attention to national and worldwide markets.

Manufacturer usually replies in 5 days

bromazepam

Tablets 1.5 mg, 3 mg, 6 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #12976
Established in the 1970s. They have a worldwide distribution network that provides customers with full sales and service support across 6 continents. They have over 4 decades of manufacturing experience. They are also a UK distributor for a high-speed DTG solution and specialize in folding and bagging systems.

Manufacturer usually replies in 6 days

bromazepam

Capsules 1.5 mg, 3 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Spain
Comments
Ref: Lexatin® (Roche)
Manufacturer #10578

Manufacturer usually replies in 6 days

bromazepam

Oral drops 2.5 mg/ml - 20 ml, 30 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #647
A pharmaceutical manufacturer based in the EU that is active for 20+ years. Key production lines are Rx, OTC, nutraceuticals, and cosmetics. The company's production lines are GMP-compliant. The main therapeutic areas include antiviral, anti-inflammatory, and antifungal. The main dosage forms are oral solid and topical forms.

Manufacturer usually replies in 16 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

bromazepam

Tablets 1.5 mg, 3 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
North Macedonia
GMP approvals
EU GMP
Registered in
North Macedonia
Manufacturer #17662
For over 25 years, the company has been specialty license holders and developers with their own staff working on innovative formulations and presentations. Own-label pharmaceutical, generic, and grocery markets expertise. Own-brand product made in an MHRA-approved facility. Reinvestment in new product development and approvals is ongoing. Export products to the Far East and Asia. Importing from outside the EU is a familiar concept.

Manufacturer usually replies in 6 days

bromazepam

Tablets 12 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Uruguay
GMP approvals
WHO
Manufacturer #21285
It is a pharmaceutical company with more than 90 years of leadership in Latin America's market, which researches, develops, produces, represents, and distributes effective, reliable, and accessible products in all therapeutic areas for health care.

Manufacturer usually replies in 2 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #17750

Manufacturer usually replies in 4 days

bromazepam

Tablets 3mg, 6mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
FDA
Manufacturer #8698
It has a multi-purpose chemical and pharmaceutical plant with over 17 years of experience producing Active Pharmaceutical Ingredients (APIs). The company aims to be a leader in the creation of active pharmaceutical ingredients for human health care, with the quality, service, and pricing that enable it to compete internationally and improves the quality of life for the patients of the company.

Manufacturer usually replies in 6 days

bromazepam

Tablets 1.5 mg, 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

bromazepam

Tablets 1.5 mg, 3 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Manufacturer #8016
It was established in the early 1990s for manufacturing various pharmaceutical dosage forms and marketing them. The company is into Penicillin based formulations, Hormone based formulations, and Cephalosporin based formulations. A wide therapeutic range is covered by the company products viz. antibiotics, anti-microbial agents, anti-parasites, anti-viral, anxiolytic & anti-depressants, capillary regulators, CNS stimulants, peripheral & cerebral vasodilators, anti-hypertensive agents, hormones, analgesics & anti-inflammatory agents, respiratory drugs, gastrointestinal drugs, iron preparations, anti-hyperglycemic agents, diuretics and anti-gout preparations.

Manufacturer usually replies in 9 days

bromazepam

Tablets 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

bromazepam

Tablets 1.5 mg, 3 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

bromazepam

Tablets 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Paraguay
GMP approvals
WHO
Manufacturer #18676
It is one of the leading pharmaceutical companies. Its main objective is to satisfy consumer needs through the production of high-quality drugs and to contribute to the preservation of people’s health. The company is permanently investing in technology to adapt to internationally accepted good manufacturing practice standards (GMP-Good Manufacturing Practice).

Manufacturer usually replies in 5 days

bromazepam

Tablets 3mg, 6mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16330
It was established in the 1990s as a modern and powerful independent national chemical-pharmaceutical industry, the company develops a growing activity in pursuit of excellence in medicinal specialties for human use, researching and developing new products, innovative pharmaceutical forms, and applying technologies that highlight its presence in the International pharmaceutical industry sector, providing therapeutic solutions to the most varied pathologies suffered by the population. They have 500+ products and 14000+ meters of pharmaceutical plant.

Manufacturer usually replies in 5 days

Want to view all 30 products? Create your free account today!

Bromazepam:

Bromazepam, also known by its popular brand name of Lectopam, is an anti-anxiety medication with similar therapeutic effects and side effects to diazepam (Valium). It is predominantly used in the treatment of anxiety or panic states, as such, it has become a popularly prescribed premedication before surgery. It was originally produced by the pharmaceutical products company Roche, which patented it in 1961 and got it subsequently approved for commercialization on the medical marketplace in 1974. Currently, it has entered into the generic drugs space, commonly being produced and listed for sale by Bromazepam manufacturers and Bromazepam suppliers. However, due to its psychotropic properties and frequent abuse, it is classified as a schedule IV drug in the U.S. and Canada under the Convention on Psychotropic Substances, hindering its commercialization by manufacturers. Regardless, as a generic drug, it is often found available to order on the pharmaceutical products list of distributors across the global marketplace, where it can be found wholesale at a variety of cost and price points.

Method of action of Bromazepam:

Bromazepam belongs to a group of pharmaceutical products termed benzodiazepines. Specifically, it is a lipophilic, long and intermediate-acting benzodiazepine with sedative, hypnotic, anxiolytic, and skeletal muscle relaxant properties. It functions by binding to the GABA-A receptor, producing a conformational change and causing downstream effects, which in turn culminate in the observed clinical properties. Notably, it is specific in its activation, with other neurotransmitters not being influenced.

Form and dosage of Bromazepam:

The final form and packaging of Bromazepam are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, Bromazepam can typically be found wholesale in forms including tablets, oral drops, and capsules. For the treatment of excessive anxiety in adults, the typical dose ranges from 6 mg to 18 mg daily. This can be adjusted by the prescribing medical official, up to a recommended maximum dose of a total of 30 mg daily. The length of treatment should not exceed one week unless specifically prescribed as unwanted side effects may occur. Such as dependence and withdrawal symptoms when taken for extended periods. For a complete list of possible adverse effects please refer to the manufacturers’ literature or contact the prescribing healthcare provider.

Bromazepam on Pipelinepharma:

Currently, at the time of writing, we have found 15 verified bromazepam manufacturers and bromazepam suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located globally in countries including Mexico, the European Union, Brazil, and Jordan. Every company and their pharmaceutical product list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability while serving to reduce souring mileage, allowing for a fluent business experience for all involved parties.

Price of Bromazepam and how to buy:

A cursory search online reveals an approximate cost for wholesale Bromazepam to be 514- 722 USD/kg from India and 1,693 USD/kg from Italy. It should be noted that these indicated values do not represent finished dosage formulations and the price of Bromazepam, as with any drug, is highly dependent on the individual situation. As such, these indicated values only serve as a generalisation of the current market condition.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.